Bank Of New York Mellon Corp Precigen, Inc. Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.27 - $2.26 $424,919 - $756,155	334,582 New	334,582 $508,000
Q3 2022 Nov 14, 2022	BUY	$1.41 - $2.79 $30,792 - $60,930	21,839 Added 6.94%	336,337 $713,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $4,706 - $10,355	-4,093 Reduced 1.28%	314,498 $421,000
Q1 2022 May 11, 2022	SELL	$1.91 - $3.98 $34,229 - $71,325	-17,921 Reduced 5.33%	318,591 $672,000
Q4 2021 Feb 11, 2022	SELL	$3.53 - $5.5 $26,072 - $40,623	-7,386 Reduced 2.15%	336,512 $1.25 Million
Q3 2021 Nov 12, 2021	BUY	$4.99 - $6.55 $134,410 - $176,430	26,936 Added 8.5%	343,898 $1.72 Million
Q2 2021 Aug 11, 2021	BUY	$6.24 - $8.22 $97,737 - $128,749	15,663 Added 5.2%	316,962 $2.07 Million
Q1 2021 May 13, 2021	BUY	$6.74 - $10.95 $131,221 - $213,185	19,469 Added 6.91%	301,299 $2.08 Million
Q4 2020 Feb 09, 2021	BUY	$3.75 - $10.56 $2,546 - $7,170	679 Added 0.24%	281,830 $2.87 Million
Q3 2020 Nov 12, 2020	SELL	$3.5 - $6.2 $14,672 - $25,990	-4,192 Reduced 1.47%	281,151 $984,000
Q2 2020 Aug 12, 2020	SELL	$2.16 - $5.46 $36,951 - $93,404	-17,107 Reduced 5.66%	285,343 $1.42 Million
Q1 2020 May 06, 2020	BUY	$1.46 - $7.19 $441,577 - $2.17 Million	302,450 New	302,450 $1.03 Million

142

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $235M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.